Skip to main content

Roser Solans Laque

Institutions of which they are part

Systemic Diseases
Vall Hebron Institut de Recerca

Roser Solans Laque

Institutions of which they are part

Systemic Diseases
Vall Hebron Institut de Recerca

Research lines

Genetic bases of giant cell arteritis (GCA).

With this study we aim to investigate the genetic background of the disease, to deepen in its pathogenesis and to be able to establish links between genetic variations and different clinic and biologic patterns. This research is based on a multicentric study and it is led by Prof. Javier Martín from the "Instituto López-Neyra" of Parasitology, CSIC (Granada). We contribute by sending samples from our cohort of patients along with the clinical data, and reviewing the results.

IP: Roser Solans Laque

Spanish Registry of patients with Systemic vasculitides (REVAS).

This is a multicentre study supported by the Systemic Autoimmune Diseases Group (GEAS) from the Spanish Internal Medicine Society (SEMI). The aim of the study is to describe the different clinical forms of presentation of these diseases, the response to the conventional treatment of the different subtypes of vasculitides, and the prognostic factors and survival in our country. This study includes 17 Hospitals from Spain with a cohort of 300 patients. We are the study coordinator Centre.

IP: Roser Solans Laque

Cardiac involvement in Churg-Strauss Granulomatosis (EGPE).

Cardiac involvement is one of the most important causes of dead in EGPE. The aim of this study is to investigate the prevalence of silent cardiac involvement in patients with EGPE, and if some chemotaxins (eotaxins 1, 2 and 3) may play a key role in its development, in order to establish an early tretament.

IP: Roser Solans Laque

Risk factors for ischemic events in biopsy-proven Giant Cell Arteritis (GCA).

The study aims to investigate the risk factors for ischemic complications in patients with GCA, and the role that some endothelial growth factors may play in its development. This study is coordinated by Dr. Gonzalez Gay from University Hospital of Valdecilla, Santander.

IP: Roser Solans Laque

Projects

Ajuts Grups de Recerca (SGR) 2022

IP: Jaume Alijotas Reig
Collaborators: Moisés Labrador Horrillo, Carmen Pilar Simeón i Aznar, Anna Sala Cunill, Roser Solans Laque, Segundo Bujan Rivas, Mar Guilarte Clavero, Vicenç Fonollosa Pla, Fernando Martínez Valle, Victòria Cardona Dahl, Francesc Miro Mur, Alfredo Guillen Del Castillo, Albert Selva O'Callaghan, José Pardos Gea, Laura Donaire Lancharro, Ariadna Anunciacion Llunell
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 0.01
Reference: 2021 SGR 00048
Duration: 01/01/2022 - 30/06/2025

Autoimmunitat i Malaltia Trombòtica (GRC)

IP: Miguel Vilardell Tarres
Collaborators: Carmen Pilar Simeón i Aznar, Roser Solans Laque, Segundo Bujan Rivas, Vicenç Fonollosa Pla, José Ordi Ros, José Ángel Bosch Gil, Josefina Cortes Hernandez, Fernando Martínez Valle, Albert Selva O'Callaghan, Cristina Solé Marce
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding:
Reference: 2014 SGR 329
Duration: 01/01/2014 - 31/12/2016

Estudio clínico e inmunológico de la afección cardíaca en fase de remisión clínica de la Poliangeítis con Granulomatosis eosinofílica

IP: Roser Solans Laque
Collaborators: -
Funding agency: Mutual Mèdica de Catalunya i Balears
Funding: 4000
Reference: 2014\BMM\SOLANS
Duration: 27/11/2014 - 26/11/2015

Determinación del riesgo de afectación extraglandular y desarrollo de linfoma en el Síndrome de Sjögren primario mediante estudio de poblaciones linfocitarias y citocinas en sangre y tejido

IP: Roser Solans Laque
Collaborators: Carlos Palacio García, Margarita Alberola Ferranti, Fernando Martínez Valle
Funding agency: Instituto de Salud Carlos III
Funding: 35695
Reference: PI13/00655
Duration: 01/01/2014 - 30/06/2018

Related news

Researchers have used an innovative protocol to identify people with this autoimmune disease who have a higher risk of cancer.

It will allow the promotion of research on systemic autoimmune-based diseases that especially affect women of childbearing age and, therefore, can also appear during pregnancy.

The study showing how thrombocytopenia increases the risk of thrombosis in patients with antiphospholipid syndrome has been considered the best paper published in 2021.

Related professionals

Maria Gutiérrez-San Miguel Guilera

Maria Gutiérrez-San Miguel Guilera

Read more
Laura  Hernandez  Castro

Laura Hernandez Castro

Research technician
Multidisciplinary Nursing Research Group
Read more
Iñaki Mimendia  Sancho

Iñaki Mimendia Sancho

Senior researcher
Reconstructive Surgery of the Locomotor System
Read more
Mònica Velasco Nuño

Mònica Velasco Nuño

Molecular Medical Imaging
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.